Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXP7X7
|
||||
| Drug Name |
(S)-N-(1-(cyanomethylamino)-1-oxo-3-(3-(pyridin-4-yl)phenyl)propan-2-yl)benzamide
|
||||
| Synonyms |
CHEMBL556504
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H20N4O2
|
||||
| Canonical SMILES |
O=C(NCC#N)[C@H](Cc1cccc(c1)c2ccncc2)NC(=O)c3ccccc3
|
||||
| InChI |
InChI=1S/C23H20N4O2/c24-11-14-26-23(29)21(27-22(28)19-6-2-1-3-7-19)16-17-5-4-8-20(15-17)18-9-12-25-13-10-18/h1-10,12-13,15,21H,14,16H2,(H,26,29)(H,27,28)/t21-/m0/s1
|
||||
| InChIKey |
STJLGGUWJOEIHR-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.